A7D-13650-43859
4 vaccinations
10 coded responses
22 check-ins
10 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 891 / NV
- Registered
- 2021-09-12
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-25
Dose 1 — Pfizer-BioNTech
-
2021-09-12
Registered in v-safe
-
2021-09-12
Dose 2 — Pfizer-BioNTech
- 2021-09-12
-
2021-09-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-09-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-19
Health check-in — day 7, dose 2Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-26
Survey response — day 14, dose 2MedDRA: Arthralgia, Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: Continued joint pain (6out10); headaches(7out10);MedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — day 21, dose 2MedDRA: Cough, Myalgia, Pollakiuria, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sniffles, coughing, frequent urination, more intense muscle achesMedDRA releases: 2024-11 · check-in free text available
- 2021-10-10
-
2021-10-17
Survey response — day 35, dose 2MedDRA: Arthralgia, Headache, Myalgia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Muscle & Joint aches, headachesMedDRA releases: 2024-11 · check-in free text available
-
2021-10-25
Survey response — day 42, dose 2MedDRA: Arthralgia, Dry mouth, Myalgia, Vision blurred — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Joint aches & pain, muscle aches & pain, blurry vision, dry mouthMedDRA releases: 2024-11 · check-in free text available
-
2021-12-12
Survey response — 3 months, dose 2MedDRA: Back pain, Headache, Muscle spasms — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Serious leg cramps snd lower back pain, along with level 10 headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-02-21
Dose 3 — Pfizer-BioNTech
-
2022-03-13
Survey response — 6 months, dose 2MedDRA: Arthralgia, Back pain, Cough, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: joint aches, lower back pain, chest congestion, coughimgMedDRA releases: 2024-11 · check-in free text available
-
2022-09-12
Survey response — 12 months, dose 2MedDRA: Arthralgia, Cough, Oropharyngeal pain, Vision blurred — Feeling: Fair · Be unable to do your normal daily activitiesFree text: joint pain, sore throat, cough, blurry visionMedDRA releases: 2024-11 · check-in free text available
-
2022-09-19
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-24
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-09-25
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-09-26
Health check-in — day 7, dose 4Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-10-03
-
2022-10-18
Survey response — day 28, dose 4MedDRA: Arthralgia, Asthenia, Myalgia — Feeling: Poor · Be unable to do your normal daily activitiesFree text: more muscle & joint aches, and no energyMedDRA releases: 2024-11 · check-in free text available
-
2022-11-04
Survey response — day 42, dose 4MedDRA: Arthralgia, Back pain, Migraine — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: back & joint pain, migraine headachesMedDRA releases: 2024-11 · check-in free text available
-
2022-11-04
Report sent to call center — day 42, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-07
-
2022-12-20
Survey response — 3 months, dose 4MedDRA: Arthralgia, Dysstasia, Gait disturbance, Insomnia, Myalgia, Sitting disability — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: muscle & joint pain continues, making walking, sitting, standing anf sleep difficultMedDRA releases: 2024-11 · check-in free text available
-
2022-12-20
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-12-21
- 2022-12-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-25 | Pfizer-BioNTech | No |
| 2 | 2021-09-12 | Pfizer-BioNTech | No |
| 3 | 2022-02-21 | Pfizer-BioNTech | No |
| 4 | 2022-09-19 | Pfizer-BioNTech | Flu |
Call center
2 call center cases
2 unsuccessful
Free text
Release 9 — day 14, dose 2
Symptoms: Continued joint pain (6out10); headaches(7out10);
Release 10 — day 21, dose 2
Symptoms: Sniffles, coughing, frequent urination, more intense muscle aches
Release 10 — day 35, dose 2
Symptoms: Muscle & Joint aches, headaches
Release 10 — day 42, dose 2
Symptoms: Joint aches & pain, muscle aches & pain, blurry vision, dry mouth
Release 10 — 3 months, dose 2
Symptoms: Serious leg cramps snd lower back pain, along with level 10 headache
Release 11 — 6 months, dose 2
Symptoms: joint aches, lower back pain, chest congestion, coughimg
Release 12 — 12 months, dose 2
Symptoms: joint pain, sore throat, cough, blurry vision
Release 12 — day 28, dose 4
Symptoms: more muscle & joint aches, and no energy
Release 12 — day 42, dose 4
Symptoms: back & joint pain, migraine headaches
Release 12 — 3 months, dose 4
Symptoms: muscle & joint pain continues, making walking, sitting, standing anf sleep difficult
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Back pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dry mouth | · | · | ✓ |
| SD | Dysstasia | · | · | ✓ |
| SD | Gait disturbance | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Muscle spasms | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pollakiuria | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sitting disability | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release